Garima T.

The curiosity to unravel biological secrets using computational tools motivated me to take up Bioinformatics since my B.Tech. At the inception times towards the subject, I was deeply fascinated in gaining the knowledge of drug designing, Chemoinformatics, Comparative and Functional Genomics, Clinical trials and database management. <br/> <br/>PROJECTS: <br/> <br/>â?¢ FINAL YEAR PROJECT (M.Sc. 4th Semester): â??PATHWAY ANALYSIS FOR HUMAN BLOOD METABOLITES SHOWING AGE-RELATED VARIABILITYâ??. PLACE: Department of Bioinformatics- BiGCaT <br/>Maastricht University, The Netherlands. <br/>â?¢ MINI PROJECT (M.Sc. 3rd Semester): â??IN SILICO STUDY OF ONE CARBON FOLATE PATHWAY USING FLUX ANALYSISâ??. <br/>â?¢ FINAL YEAR PROJECT (B.Tech. 8th Semester): â??COMPUTER-AIDED DESIGN OF POTENT NOSCAPINE ANALOGS AND EVALUATION AS ANTI-CANCER DRUGSâ??. PLACE: Department of Biotechnology and Bioinformatics <br/>Jaypee University of Information Technology, Solan, India. <br/>TEAM SIZE: 2. <br/>â?¢ CLASS PROJECT (B.Tech. 4th Semester): Developed a PROMOTER PREDICTION TOOL. <br/>PLACE: Department of Biotechnology and Bioinformatics Jaypee University of Information Technology, Solan, India. <br/> <br/>WORK EXPERIENCE: <br/>â?¢ Designation:- QA Officer. <br/>Company:- Chiros Pharma. Duration:- 01-12-2016 to 15-07-2017 <br/>â?¢ Designation:- Bioinformatics Analyst. Company:- Eminent Biosciences. <br/>Duration:- 10-01-2018 to current date <br/> <br/>PUBLICATION: <br/>â?¢ Sinha K, Patidar K, Thakur G, Majhi M, Sweta J, Ali M A, Hood E A, Nayarisseri A, "Structure-based virtual screening approach for the identification of potential anti-cancer compounds targeting CD20 for the treatment of Chronic Lymphocytic Leukemia (CLL)." Accepted in Anti-Cancer Agents in Medicinal Chemistry.